Cargando…
Multi-Criteria Decision Analysis (MCDA) Models in Health Technology Assessment of Orphan Drugs—a Systematic Literature Review. Next Steps in Methodology Development?
Background: Multi-criteria decision analysis (MCDA) is a decision-making tool that can take into account multidimensional factors and enables comparison of (medical) technologies by combining individual criteria into one overall appraisal. The MCDA approach has slowly gained traction within Health T...
Autores principales: | Baran-Kooiker, Aleksandra, Czech, Marcin, Kooiker, Coen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197072/ https://www.ncbi.nlm.nih.gov/pubmed/30374435 http://dx.doi.org/10.3389/fpubh.2018.00287 |
Ejemplares similares
-
A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countries
por: Czech, Marcin, et al.
Publicado: (2020) -
Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugs
por: Schey, C., et al.
Publicado: (2017) -
Multi-Criteria Decision Analysis for Assessment and Appraisal of Orphan Drugs
por: Iskrov, Georgi, et al.
Publicado: (2016) -
Using Multiple Criteria Decision Analysis (MCDA) to make coverage decisions: a methodological framework
por: Kanavos, Panos, et al.
Publicado: (2015) -
Potential impact of the implementation of multiple-criteria decision analysis (MCDA) on the Polish pricing and reimbursement process of orphan drugs
por: Kolasa, Katarzyna, et al.
Publicado: (2016)